Mobility Limitation: Clinical Trials

15 trials for Mobility Limitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 6 recruiting, 1 terminated, 1 unknown. 15 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 215Completed 7, Recruiting 6, Terminated 1, Unknown 1
Phase 33Completed 1, Recruiting 1, Terminated 1
Phase 12Completed 1, Recruiting 1

Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Living Independence Through Functional Training
Task-oriented resistance exercise - Mobility Limitation, Cognitive Impairment
Phase 1 / Phase 2RecruitingUniversity of Florida152026-01-062026-07-31
Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance
Functional Activity Strength Training - Mobility Limitation
Phase 2 / Phase 3RecruitingMilton S. Hershey Medical Center3602025-04-092026-07-22
Response to Exercise and Nitric Oxide in PAD
Supervised Treadmill Exercise, Attention Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy - Peripheral Artery Disease, Exercise
Phase 2RecruitingNorthwestern University2002025-01-232026-07-27
Fisetin to Reduce Senescence and Mobility Impairment in PAD
Fisetin, Placebo - Peripheral Arterial Disease, Aging
Phase 2RecruitingNorthwestern University342024-09-302026-11-16
Passive Stretching in Peripheral Arterial Disease Patients
Calf Plantar flexion, Dietary nitrate - Peripheral Arterial Disease, Walking, Difficulty
Phase 2RecruitingUniversity of Wisconsin, La Crosse642024-05-202025-04-02
Heat Therapy, Functional Capacity, and Vascular Health in Older Adults
Home-based leg heat therapy, Home-based sham therapy - Aging Well, Walking, Difficulty
Phase 1 / Phase 2CompletedUniversity of North Texas Health Science Center212022-11-032026-06-05
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Testosterone Enanthate, Locomotor Training - Spinal Cord Injury, Spinal Cord Injuries
Phase 2RecruitingNorth Florida Foundation for Research and Education212021-01-312025-05-06
Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease
Adrabetadex - Niemann-Pick Disease, Type C
Phase 2 / Phase 3TerminatedMandos LLC662015-12-232023-08-29
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C
Phase 2 / Phase 3CompletedMandos LLC562015-10-012023-02-22
Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty
denosumab - Osteoarthritis, Hip, Ambulation Difficulty
Phase 2CompletedHans Mallmin642012-08-072017-04-05
Experimental Control Investigation of the Impact of Assistive Technology on the User-caregiver Dyad: a Multi-site Trial
Assistive technology updating and tune up intervention - Mobility Limitations
Phase 2CompletedCentre de Recherche de l'Institut Universitaire de Geriatrie de Montreal882009-06-012014-02-19
Effects of Game-based Balance Exercise for Older Adults With Fall History
game-based balance exercises - Mobility Limitation
Phase 2CompletedUniversity of Manitoba302007-08-012011-06-27
The APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's Disease
APOS System - biomechanical wedge shoe - Idiopathic Parkinson's Disease
Phase 2UnknownTel-Aviv Sourasky Medical Center602007-08-012007-07-10
Restoring Skill in Walking
gait intervention - Mobility Limitation
Phase 2CompletedUniversity of Pittsburgh482005-11-012007-12-13
Increasing Physical Activity Among Overweight Women With Mobility Disabilities.
Personalized exercise programme (PEP) - Obesity
Phase 2CompletedCenters for Disease Control and Prevention962004-10-012019-07-26

Narrower conditions

Cognitive Dysfunction (3)  ·  Motor Activity (3)  ·  Peripheral Arterial Disease (3)  ·  Deglutition Disorders (2)  ·  Disease (2)  ·  Intermittent Claudication (2)  ·  Niemann-Pick Disease, Type C (2)  ·  Bone Resorption (1)  ·  Central Nervous System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Gait Disorders, Neurologic (1)  ·  Genital Diseases, Male (1)  ·  Gonadal Disorders (1)  ·  Hyperemia (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (15)  ·  Signs and Symptoms (15)  ·  Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Arterial Occlusive Diseases (3)  ·  Arteriosclerosis (3)  ·  Atherosclerosis (3)  ·  Behavior (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cognition Disorders (3)  ·  Mental Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurocognitive Disorders (3)  ·  Nutritional and Metabolic Diseases (3)

Interventions

2-Hydroxypropyl-beta-cyclodextrin (2)  ·  Cyclodextrins (2)  ·  Denosumab (1)  ·  fisetin (1)  ·  testosterone enanthate (1)

Sponsors

Mandos LLC (2)  ·  Northwestern University (2)  ·  Centers for Disease Control and Prevention (1)  ·  Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal (1)  ·  Hans Mallmin (1)  ·  Milton S. Hershey Medical Center (1)  ·  North Florida Foundation for Research and Education (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University of Florida (1)  ·  University of Manitoba (1)  ·  University of North Texas Health Science Center (1)  ·  University of Pittsburgh (1)  ·  University of Wisconsin, La Crosse (1)

Countries

United States (11)  ·  Australia (2)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  New Zealand (2)  ·  Singapore (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Chiung-ju Liu Associate Professor, phD (1)  ·  Dana M Otzel, Phd (1)  ·  Hans Mallmin, MD, PhD (1)  ·  Jacob T Caldwell, Ph.D. (1)  ·  James Rimmer, Ph.D. (1)  ·  Jessie VanSwearingen, PhD, PT (1)  ·  Joshua F Yarrow, PhD (1)  ·  Louise Demers, PhD (1)  ·  Maggie Nellissery, Ph.D. (1)  ·  Nils Hailer, MD, PhD (1)  ·  Nir Giladi, MD (1)  ·  Tony Szturm, BSc(PT), PhD (1)

Results publications

PMID 19459233, PMID 21799138, PMID 22003158, PMID 31589776, PMID 40525490, PMID 40584156, PMID 41921101, PMID 42035974

NIH funding

2015 (2), R01AG079938 (1)